JB Jonas - Ophthalmic Res, 2006 - content.karger.com Background: Based on experimental studies and clinical observations by Robert
Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been
used as a reservoir of drugs for the direct treatment of intraocular ... Cited by 46 - Related articles - BL Direct - All 5 versions
F Audren, A Lecleire-Collet, A Erginay, B … - American journal of ophthalmology, 2006 - Elsevier Before injection, mean (± SD) CMT was 564.5 ± 119 μm and 522.9 ± 148.5 μm
in the 4- and 2-mg groups, respectively. At four, 12, and 24 weeks after
injection, it was 275.0 ± 79.8, 271.4 ± 128.7, and 448.7 ± 146.4 μm, ... Cited by 40 - Related articles - All 26 versions
- ►duanesolution.com S Sivaprasad, P McCluskey, S Lightman - Acta Ophthalmologica Scandinavica, 2006 - pt.wkhealth.com The use of intravitreal corticosteroids in the management of macular oedema has
recently gained widespread acceptance. New long-acting steroid preparations and
methods of delivery have facilitated the use of these new modalities. This ... Cited by 29 - Related articles - BL Direct - All 6 versions
D Ghate, HF Edelhauser - Expert Opin. Drug Deliv., 2006 - Informa Pharma Science Drug delivery to the eye is hampered by anatomical factors, including the
corneal epithelium, the blood–aqueous barrier and the blood–retinal barrier.
This review aims to outline the major routes of ocular drug delivery, ... Cited by 27 - Related articles - BL Direct - All 5 versions
W Kai, J Yanrong, L Xiaoxin - Graefe's Archive for Clinical and Experimental …, 2006 - Springer Abstract Background: Intravitreal triamcinolone acetonide (TA) has been widely
used as a therapeutic method for many ocular diseases, but a consensus on an
appropriate safe therapeutic window of dosage for intravitreal injection, ... Cited by 22 - Related articles - BL Direct - All 2 versions
B van Kooij, A Rothova, P de Vries - Ocular immunology and inflammation, 2006 - informahealthcare.com Intravitreal triamcinolone acetonide (IVTA) injections are gaining in popularity
and are regularly administered nowadays for various ocular diseases. This paper
presents a literature review on the use, efficacy, and complications of ... Cited by 17 - Related articles - BL Direct - All 6 versions
TA Macky, D Helmy, N El Shazly - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Purpose To assess retinal toxicity of the vehicle of triamcinolone,
benzyl alcohol (BA), when injected into the vitreous cavity of rabbits. Methods
This prospective comparative experimental study included 24 pigmented ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►iovs.org ME Hartnett, DJ Martiniuk, Y Saito, P Geisen … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Newborn rats exposed to OIR underwent intravitreous injections (right
eye) at day 14 to achieve intravitreous concentrations of: dexamethasone (DEX)
(0.3 mg/mL), triamcinolone (TA; 0.4–4 mg/mL), or PBS. Animals were ... Cited by 12 - Related articles - BL Direct - All 5 versions
